课题基金 / 基金详情

Tools for Optimizing Prescribing, Monitoring and Education

Tools for Optimizing Prescribing, Monitoring and Education
优化处方、监测和教育的工具
批准号:
7874547
负责人:
BRUCE L. LAMBERT
金额:
$97.69万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-08-31

项目摘要

项目成果

BRUCE L. LAMBERT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by the Applicant): Efforts to maximize the benefits and minimize the risks associated with drugs continue to be impeded by suboptimal prescribing, inadequate monitoring of patients' outcomes, and inadequate prescriber education and support to overcome these limitations. As a result, the US healthcare system suffers from persistent problems of underuse, overuse and misuse of drugs, with unacceptably high rates of preventable errors, adverse effects and suboptimal patient health outcomes. To address these problems, we propose a CERT organized around the following theme: Tools for Optimizing Prescribing, Monitoring and Education (TOP-MED). The long term objective of our CERT is to improve the safety, efficacy and cost-effectiveness of drug therapy by increasing the appropriateness of prescribing and the quality of monitoring. The short term objective is to develop, redesign, refine, integrate, test, deploy and disseminate tools and training materials in five key areas: drug formularies, drug utilization review, lab-pharmacy linkages, N-of-1 trials and pharmacoeconomics. To achieve these objectives, the TOP-MED CERT will pursue the following specific aims: 1. Revitalize the drug formulary as an evidenced based tool for directing drug therapy decisions. 2. Re-engineer drug usage review (DUR) systems and processes so that data analysis is easier, more timely and more likely to yield valid generalizations. 3. Reduce prescribing errors and enhance recognition of adverse drug effects in high hazard contexts by linking lab and pharmacy information systems and generating clinical alerts when problems are detected. 4. Develop, deploy and evaluate an N-of-1 trial service, integrated into a formulary restriction program, in order to support the goal of individualized therapy without succumbing to the unsafe, unscientific experimentation that is often now the norm. 5. Implement and study the impact of pharmacoeconomic support to enhance formulary decision making, as well as evaluate the cost-effectiveness of other interventions. Cutting across these five aims will be initiatives to disseminate and deploy these tools in a more rigorous and far-reaching fashion; to provide support to make the tools easier to use; to enhance the buy-in, motivation and enthusiasm of prescribers to use the tools; to link the tools with each other in order to gain greater synergies, and to share the knowledge gained and lessons learned across multiple institutions. Headquartered at the University of Illinois at Chicago (UIC), and leveraging collaborations with the Cook County Bureau of Health Services, Northwestern Memorial Hospital, University of Washington, the VA Center for Medication Safety, Advocate Health Care, the Illinois Hospital Association and the Illinois Department of Public Health, the TOPMED CERT will be able to focus on the needs of multiple AHRQ priority populations.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Economic analysis of alvimopan for prevention and management of postoperative ileus.
阿维莫泮预防和治疗术后肠梗阻的经济分析。
DOI: 10.1002/phar.1047
发表时间: 2012
期刊: Pharmacotherapy
影响因子: 4.1
作者: [Touchette,DanielR, Yang,Yoojung, Tiryaki,Funda, Galanter,WilliamL]
通讯作者: Galanter,WilliamL
DOI: 10.1371/journal.pmed.1001220
发表时间: 2012
期刊: PLoS medicine
影响因子: 15.8
作者: [Schiff GD, Galanter WL, Duhig J, Koronkowski MJ, Lodolce AE, Pontikes P, Busker J, Touchette D, Walton S, Lambert BL]
通讯作者: Lambert BL
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
医院预防和治疗耐甲氧西林金黄色葡萄球菌感染的政策和做法。
DOI: 10.2146/ajhp090563
发表时间: 2010
期刊: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
影响因子: --
作者: [Yang,Yoojung, McBride,MartinV, Rodvold,KeithA, Tverdek,Frank, Trese,AnneMarie, Hennenfent,Joel, Schiff,Gordon, Lambert,BruceL, Schumock,GlenT]
通讯作者: Schumock,GlenT
Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: results of a Delphi survey.
住院异步警报程序的药物实验室结果对的选择:德尔福调查的结果。
DOI: 10.2146/ajhp100215
发表时间: 2011
期刊: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
影响因子: --
作者: [Yu,Shengsheng, Galanter,WilliamL, DiDomenico,RobertJ, Borkowsky,Shane, Schiff,GordonD, Lambert,BruceL]
通讯作者: Lambert,BruceL
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
  • 批准号:
    9356494
  • 项目类别:
  • 资助金额:
    $39.65万
  • 财政年份:
    2016
  • 负责人:
    BRUCE L. LAMBERT
  • 依托单位:
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
  • 批准号:
    10013218
  • 项目类别:
  • 资助金额:
    $39.16万
  • 财政年份:
    2016
  • 负责人:
    BRUCE L. LAMBERT
  • 依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
  • 批准号:
    8739629
  • 项目类别:
  • 资助金额:
    $84.08万
  • 财政年份:
    2011
  • 负责人:
    BRUCE L. LAMBERT
  • 依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
  • 批准号:
    8265048
  • 项目类别:
  • 资助金额:
    $84.88万
  • 财政年份:
    2011
  • 负责人:
    BRUCE L. LAMBERT
  • 依托单位:
海外基金